| Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia S Ganesan, AA Alex, E Chendamarai, N Balasundaram, HK Palani, ... Leukemia 30 (11), 2169-2178, 2016 | 44 | 2016 |
| Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia S Ganesan, HK Palani, V Lakshmanan, N Balasundaram, AA Alex, ... Cell death & disease 10 (10), 736, 2019 | 36 | 2019 |
| Arsenic trioxide enhances the NK cell cytotoxicity against acute promyelocytic leukemia while simultaneously inhibiting its bio-genesis AA Alex, S Ganesan, HK Palani, N Balasundaram, S David, KM Lakshmi, ... Frontiers in Immunology 9, 1357, 2018 | 20 | 2018 |
| Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens NA Fouzia, V Sharma, S Ganesan, HK Palani, N Balasundaram, S David, ... British journal of haematology 192 (2), 292-299, 2021 | 19 | 2021 |
| A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide U Kulkarni, S Ganesan, AA Alex, H Palani, S David, N Balasundaram, ... Cancer Medicine 9 (8), 2603-2610, 2020 | 19 | 2020 |
| Combination lenalidomide/bortezomib treatment synergistically induces calpain-dependent ikaros cleavage and apoptosis in myeloma cells S Ganesan, HK Palani, N Balasundaram, S David, AJ Devasia, B George, ... Molecular Cancer Research 18 (4), 529-536, 2020 | 18 | 2020 |
| Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population S David, SC Nair, GS Singh, AA Alex, S Ganesan, HK Palani, ... Haemophilia 25 (1), 67-74, 2019 | 15 | 2019 |
| Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia UP Kulkarni, S Selvarajan, S Lionel, MA Prakash, HK Palani, ... Blood cancer journal 12 (1), 22, 2022 | 12 | 2022 |
| Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia N Balasundaram, S Ganesan, E Chendamarai, HK Palani, ... Blood advances 6 (2), 652-663, 2022 | 9* | 2022 |
| Metabolic crosstalk between stromal and malignant cells in the bone marrow niche HA Tirado, N Balasundaram, L Laaouimir, A Erdem, N Van Gastel Bone Reports 18, 101669, 2023 | 6 | 2023 |
| Suppression of different classes of somatic mutations in Arabidopsis by vir gene-expressing Agrobacterium strains JM Shah, AM Ramakrishnan, AK Singh, S Ramachandran, ... BMC plant biology 15, 1-13, 2015 | 5 | 2015 |
| Arsenic trioxide resistance: more to it than mutations in PML-RARα AA Alex, E Chendamarai, S Ganesan, N Balasundaram, HK Palani, ... Blood 124 (21), 3605, 2014 | 4 | 2014 |
| Haploidentical Natural Killer Cell Therapy As an Adjunct to Stem Cell Transplantation for Refractory Acute Myeloid Leukemia U Kulkarni, AK Arunachalam, HK Palani, N Balasundaram, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | 1 | 2022 |
| Targeting extracellular vesicle secretion as a strategy to overcome microenvironment mediated drug resistance in acute myeloid leukemia PK Kumar, S Ganesan, N Balasundaram, S David, A Venkatraman, ... Blood 134, 3733, 2019 | 1 | 2019 |
| Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia HK Palani, S Ganesan, N Balasundaram, A Venkatraman, A Korula, ... Scientific Reports 14 (1), 8404, 2024 | | 2024 |
| Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia HK Palani, S Ganesan, N Balasundaram, A Venkatraman, U Kulkarni, ... Annals of Hematology, 1-3, 2024 | | 2024 |
| Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia U Kulkarni, AK Arunachalam, HK Palani, RR Nair, N Balasundaram, ... Cell Transplantation 32, 09636897231198178, 2023 | | 2023 |
| 3197–UNDERSTANDING AND TARGETING ASPARTATE METABOLISM IN THE LEUKEMIC NICHE H Tirado, N Balasundaram, A Erdem, L Laaouimir, C Nielsen, F Leguay, ... Experimental Hematology 124, S148, 2023 | | 2023 |
| Distributive Manufacturing of CD19 CAR-T Cells Using Clinimacs Prodigy: Real-World Experience and Cost Analysis in India HK Palani, AK Arunachalam, N Balasundaram, A Venkatraman, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
| Real World Data of Concurrent Arsenic Trioxide and All-Trans Retinoic Acid with Minimal Use of Anthracycline in the Treatment of Acute Promyelocytic Leukemia UP Kulkarni, S Selvarajan, S Lionel, MA Prakash, HK Palani, ... Blood 138, 2338, 2021 | | 2021 |
